表紙
市場調査レポート

ディスポーザブルシリンジ市場

Disposable Syringe Markets

発行 TriMark Publications 商品コード 243425
出版日 ページ情報 英文 295 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
ディスポーザブルシリンジ市場 Disposable Syringe Markets
出版日: 2013年06月01日 ページ情報: 英文 295 Pages
概要

当レポートでは、ディスポーザブルシリンジ市場について調査分析し、米国をはじめとする世界市場のデータ、各市場の規模、成長率、売上予測とともに、業界の課題と潜在的脅威などを検証しながら、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 シリンジの種類:概要

  • ディスポーザブルシリンジ
  • セーフティシリンジ
  • ペンインジェクター
  • 先進インジェクションデバイス
  • ニードルフリーインジェクター

第3章 受賞したシリンジ

第4章 シリンジ業界:概要

第5章 ディスポーザブルシリンジ:市場分析

  • 医療で用いられるシリンジの量
  • 注入薬用に必要とされるシリンジサイズ
  • 非経口ドラッグデリバリー市場におけるシリンジの独占
  • 世界のディスポーザブルシリンジ市場
  • 米国の皮下注射用セーフティシリンジ市場
  • 欧州のディスポーザブルシリンジ市場
  • プレフィル市場動向
  • プレフィルシリンジからバイアルへの移行
  • プレフィルシリンジ:市場動向
  • ブランド寿命を延ばすためのプレフィルシリンジの重要性
  • プレフィルシリンジの最大市場
  • プレフィルシリンジ市場の最新動向
  • プレフィルシリンジの市場機会
  • 主なプレフィル治療薬市場における医薬品のシェア
  • プレフィルシリンジとともに使用することを目的とした特殊パイプライン薬剤
  • プレフィルシリンジの治療における使用
  • プレフィルシリンジのフレキシブル投与要件
  • プレフィルシリンジにおけるバイオテクノロジーブロックバスター
  • プレフィルシリンジで利用可能な薬剤
  • シリンジプレフィルサービスおよび製品のプロバイダー
  • 世界のプレフィルシリンジ市場
  • 米国のプレフィルシリンジ市場
  • 注入剤のためのプレフィルシリンジの急速な導入
  • プレフィルシリンジの消費
  • 医薬品のプレフィルシリンジ市場
  • インスリンペン:市場分析
  • 世界のオートインジェクター/オートインヒューザー市場
  • 世界のセイフインジェクション市場

第6章 企業プロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: TMRDSM13-0601

Abstract

This TriMark Publications report examines the disposable syringe markets as well as the supplies utilized in clinics and by patients directly in their homes to diagnose and monitor disease and to administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth in the U.S. and internationally. Unit and dollar volume are used to indicate market sizes. Additionally, this review examines industry challenges and potential threats to syringe and needle supplies manufacturers and makes strategic recommendations for boosting market share. The emphasis is on those companies actively developing and marketing products to hospitals, physicians and the general public for medically related uses.

The disposable syringe market segments are identified as:

  • 1) total reusable needle and syringe market;
  • 2) total disposable needle and syringe market;
  • 3) prefilled syringes;
  • 4) safety syringes;
  • 5) insulin injector pens;
  • 6) needleless injectors;
  • 7) vaccination injectors;
  • 8) blood collection needles and syringes;
  • 9) hypodermic needles and syringes market;
  • 10) insulin needles and syringes market;
  • 11) specialty needles and syringes market; and
  • 12) needleless injector market.

Table of Contents

1. Introduction

  • 1.1. Statement of Report
  • 1.2. About this Report
    • 1.2.1. Scope of the Report
    • 1.2.2. Objectives
    • 1.2.3. Methodology
  • 1.3. Executive Summary

2. Syringe Types: An Overview

  • 2.1. Disposable Syringes
  • 2.2. Safety Syringes
    • 2.2.1. Available Safety Syringe Technologies
    • 2.2.2. Retrofitted Syringes
    • 2.2.3. Automatically Retractable Syringes
    • 2.2.4. Manually Retractable Syringes
    • 2.2.5. Insulin Syringes
    • 2.2.6. Tuberculin Syringes
    • 2.2.7. Prefilled Syringes
      • 2.2.7.1. Components of a Prefilled Syringe
      • 2.2.7.2. Benefits of Prefills
      • 2.2.7.3. Prefills: The Future of Drug Delivery
      • 2.2.7.4. Wider Applications of Prefilled Syringes
      • 2.2.7.5. Making Improvements in Components of Prefilled Syringes
      • 2.2.7.6. Biologic Drugs and Overfill
      • 2.2.7.7. Benefits of Cyclic Olefin Polymers
      • 2.2.7.8. Overcoming Variability in Glass Syringes
      • 2.2.7.9. Impact of Silicone Oil on Delivery
      • 2.2.7.10. Migrating Risk for Protein Aggregation
      • 2.2.7.11. Key Advantages of Prefilled Syringes
    • 2.2.8. Production of Standard Prefilled Syringes
      • 2.2.8.1. Attachment of Safety Features in Prefilled Syringes
    • 2.2.9. Available Prefilled Syringes in the Market
      • 2.2.9.1. Baxter BioPharma Solutions
      • 2.2.9.2. BD Medical's Prefilled Segment
      • 2.2.9.3. Catalent Pharma Solutions
      • 2.2.9.4. Cook Pharma's Filling and Packaging
      • 2.2.9.5. Gerresheimer AG's Syringe Designs
      • 2.2.9.6. Unilife Corporation's New Approach
      • 2.2.9.7. West Pharmaceutical Services, Inc.'s Prefilled Syringes
  • 2.3. Pen Injectors
    • 2.3.1. Insulin Pens
    • 2.3.2. Buyer's Guide for Reusable Insulin Pens
      • 2.3.2.1. Technical Considerations for Insulin Pens
      • 2.3.2.2. Technical Considerations for Insulin Cartridges
      • 2.3.2.3. Technical Considerations for Pen Needles
      • 2.3.2.4. Device Considerations
      • 2.3.2.5. User Considerations
    • 2.3.3. Market Review of Selected Insulin Pens
      • 2.3.3.1. Autopen 24 and Autopen Classic from Owen Mumford
      • 2.3.3.2. HumaPen Luxura and Luxura HD from Eli Lilly
      • 2.3.3.3. HumaPen Memoir from Eli Lilly
      • 2.3.3.4. NovoPen 3 and NovoPen Junior/Demi from Novo Nordisk
      • 2.3.3.5. OptiClik from Sanofi-Aventis
      • 2.3.3.6. OptiPen Pro from Sanofi-Aventis
  • 2.4. Advanced Injection Devices
    • 2.4.1. Insulin Delivery Device Technology
    • 2.4.2. Biologic Delivery Device Technology
    • 2.4.3. Alternative Delivery Technologies
  • 2.5. Needle-Free Injectors
    • 2.5.1. Needleless Injector from Injex
    • 2.5.2. Jet Syringes from Injex
    • 2.5.3. Syrijet
    • 2.5.4. PenJet
    • 2.5.5. Needle-Free Injector for Human Growth Hormones

3. Award Winning Syringes

  • 3.1. Episure AutoDetect Syringe
  • 3.2. ConfiDose
  • 3.3. Humatrope Reconstitution Devices
  • 3.4. Vascez Plungerless Syringe
  • 3.5. Powr Syringe Injector
  • 3.6. NovoFine Autocover Automatic Safety Pen Needle
  • 3.7. Rev Vac Auto-Retractable Vacuum Safety Syringe

4. Syringe Industry: Overview

  • 4.1. Common Diseases Transmitted by Unsafe Needle Use and Needlesticks
  • 4.2. Most Common Instances of Needlestick Injuries
  • 4.3. Needle Phobia and Patients' Anxieties
  • 4.4. Global Transition to Safety Medical Devices
  • 4.5. U.S. Regulation
  • 4.6. Worldwide Regulation
  • 4.7. Enforcing Compliance with Sharps Safety Legislation
  • 4.8. Example of an OSHA Violation
  • 4.9. Target Market Awaiting Premium Products
  • 4.10. Current Types of Safety Syringes
    • 4.10.1. Safety Syringes with a Needlestick Protection Device
    • 4.10.2. Needle Guard
    • 4.10.3. Needle Sheath
    • 4.10.4. Retractable Syringes
      • 4.10.4.1. Spring-Based, Non-Controlled, Retracting Needle Syringe
  • 4.11. Need for Safety Syringe Products
  • 4.12. Limitations of Existing Clinical Syringes
  • 4.13. Limitations of Existing Prefilled Syringes
  • 4.14. Market Expansion for Safety Syringes
  • 4.15. Technological Advancements in Disposable Syringes
  • 4.16. Reconstitution inside Sterile Syringes
    • 4.16.1. Vetter Lyo-Ject
  • 4.17. Plungerless Prefilled Syringes
  • 4.18. The Disposable UniJect
  • 4.19. Needle-Free Injection

5. Disposable Syringes: Market Analysis

  • 5.1. Volume of Syringes Used in Healthcare
  • 5.2. Syringe Sizes Required for Injectable Drugs
  • 5.3. Domination of Syringes in Parenteral Drug Delivery Market
  • 5.4. Global Market for Disposable Syringes
    • 5.4.1. Global Market for Disposable Syringes by Product Segmentation
    • 5.4.2. Global Market for Safety Syringes by Segmentation
    • 5.4.3. Combined Market for Injection Devices
  • 5.5. U.S. Market for Hypodermic Safety Syringes
    • 5.5.1. Disposable Syringes: U.S. Market Segments
    • 5.5.2. Types of Safety Syringes Used in U.S. Hospitals
    • 5.5.3. U.S. Adoption of Safety Syringes
    • 5.5.4. Competitive Landscape in the U.S.
    • 5.5.5. Price of Safety Syringes in the U.S.
    • 5.5.6. U.S. Disposable Syringe Market
    • 5.5.7. U.S. Safety Hypodermic Syringe Market
  • 5.6. European Market for Disposable Syringes
    • 5.6.1. European Market for Safety Syringes
  • 5.7. Prefill Market Trends
    • 5.7.1. The Shift from Vials to Prefilled Syringes
    • 5.7.2. Prefilled Syringes: Market Dynamics
    • 5.7.3. Importance of Prefilled Syringes to Extend Brand Life
    • 5.7.4. Biggest Markets for Prefilled Syringes
    • 5.7.5. Dealing with the Latest Trends in Prefilled Syringe Market
    • 5.7.6. Market Opportunities for Prefilled Syringes
    • 5.7.7. Pharmaceutical Share of Key Prefilled Therapeutic Market
    • 5.7.8. Specialty Pipeline Drugs Targeted for Use with Prefilled Syringes
    • 5.7.9. Therapeutic Usage of Prefilled Syringes
      • 5.7.9.1. Anti-Infectives in Prefilled Syringes
      • 5.7.9.2. Cardiovascular Drugs in Prefilled Syringes
      • 5.7.9.3. Central Nervous System Drugs in Prefilled Syringes
      • 5.7.9.4. Hematology Drugs in Prefilled Syringes
      • 5.7.9.5. Human Growth Hormones in Prefilled Syringes
      • 5.7.9.6. Musculoskeletal Drugs in Prefilled Syringes
      • 5.7.9.7. Obstetrics Drugs in Prefilled Syringes
      • 5.7.9.8. Oncology Drugs in Prefilled Syringes
      • 5.7.9.9. Vaccines in Prefilled Syringes
    • 5.7.10. Flexible Administration Requirements of Prefilled Syringes
    • 5.7.11. Biotech Blockbusters Available in Prefilled Syringes
    • 5.7.12. Selected Drugs Available in Prefilled Syringes
      • 5.7.12.1. Ovidrel Prefilled Syringe
      • 5.7.12.2. Enbrel Prefilled Syringe
      • 5.7.12.3. Biocon's Prefilled Safety Syringes
      • 5.7.12.4. Pegasys
      • 5.7.12.5. Afluria
      • 5.7.12.6. Enzira
      • 5.7.12.7. Fluzone Vaccine
      • 5.7.12.8. Novolin N FlexPenÔ Prefilled Insulin Syringes
      • 5.7.12.9. NovoLog® Insulin Prefilled Syringe
      • 5.7.12.10. GlaxoSmithKline's Vaccines in Prefilled Syringes
    • 5.7.13. Selected Providers of Syringe Prefilling Services and Products
      • 5.7.13.1. Althea Technologies, Inc.
      • 5.7.13.2. Althea's Clinical Manufacturing
      • 5.7.13.3. Althea's Fill/Finish Services
      • 5.7.13.4. Althea's Contract Manufacturing
    • 5.7.14. Baxter International, Inc.
      • 5.7.14.1. Baxter's Contract Manufacturing
      • 5.7.14.2. Baxter's Fill/Finish Services
      • 5.7.14.3. Baxter's Prefilled Syringes Capability
      • 5.7.14.4. Baxter's Vials
      • 5.7.14.5. Baxter's Cartridges
    • 5.7.15. Becton Dickinson and Company
      • 5.7.15.1. BD's Prefilled Syringe Services
      • 5.7.15.2. BD Hypak SCF
      • 5.7.15.3. BD Sterifill SCF
      • 5.7.15.4. BD Physioject
      • 5.7.15.5. BD Liquid Dry Disposable Pen Injector
      • 5.7.15.6. BD Pens Customized Self-Injection Systems
      • 5.7.15.7. BD Soluvia Prefillable Microinjection System
    • 5.7.16. Catalent Pharma Solutions, Inc.
    • 5.7.17. Hyaluron Contract Manufacturing
      • 5.7.17.1. Hyaluron's Syringe Filling
      • 5.7.17.2. Vetter Pharma Fertigung GmbH
      • 5.7.17.3. Vetter's Development Service
      • 5.7.17.4. Vetter's Commercial Manufacturing
    • 5.7.18. Global Market for Prefilled Syringes
      • 5.7.18.1. Steady Growth in Consumption of Prefilled Syringe Units
    • 5.7.19. U.S. Market for Prefilled Syringes
    • 5.7.20. Rapid Adoption of Prefilled Syringes for Injectables
    • 5.7.21. Pharmaceutical Consumption of Prefilled Syringes
    • 5.7.22. Market for Pharmaceutical Prefilled Syringes
      • 5.7.22.1. Global Market for Prefilled Pain Management Drugs
      • 5.7.22.2. Global Sales of Enbrel in Prefilled Syringes
      • 5.7.22.3. Global Market for Prefilled Psoriasis Drugs
      • 5.7.22.4. Global Market for Prefilled Anemia Drugs
      • 5.7.22.5. Global Market for Prefilled Disposable Insulin Delivery Devices
      • 5.7.22.6. Global Market for Insulin in Various Devices
      • 5.7.22.7. Global Market for Oncology Drugs in Prefilled Syringes
      • 5.7.22.8. Global Market for Multiple Sclerosis Drugs in Prefilled Syringes
      • 5.7.22.9. Market Leaders in Multiple Sclerosis Drugs in Prefilled Syringes
      • 5.7.22.10. Global Market for Prefilled Arthritis Drugs
      • 5.7.22.11. Global Market for Vaccines in Prefilled Syringes
      • 5.7.22.12. Market Leaders in Injectable Vaccines
      • 5.7.22.13. Market Leaders in Injectable Anticoagulants
    • 5.7.23. Market Leaders in Injectable Anti-Inflammatory Drugs
    • 5.7.24. Market Leaders in Injectable Hematology Drugs
    • 5.7.25. Market Leaders in Injectable Obstetrics Drugs
  • 5.8. Insulin Pens: Market Analysis
    • 5.8.1. Disposable Insulin Pens
    • 5.8.2. Refillable Pens
    • 5.8.3. Pen Needles
    • 5.8.4. Benefits and Patient Preferences of Insulin Pens
    • 5.8.5. Disadvantages of Pen Syringes
    • 5.8.6. Insulin Pens and Hospital Bills
    • 5.8.7. Market for Insulin Pen
  • 5.9. Global Market for Auto-Injectors/Auto-Infusers
    • 5.9.1. U.S. Leaders in Insulin Pump Market
  • 5.10. The Growth Market for Self-Injection

6. Company Profiles

  • 6.1. Abbott Laboratories
    • 6.1.1. Abbott's Syringe Products
      • 6.1.1.1. Precision Sure-Dose syringes
      • 6.1.1.2. Humira Prefilled Syringe
      • 6.1.1.3. Humira Pen
  • 6.2. Albert David Limited
  • 6.3. Alshifa Medical Syringes Manufacturing Company Ltd.
  • 6.4. Althea Technologies, Inc.
  • 6.5. Baxter International, Inc.
    • 6.5.1. Baxter's Anesthesia Business
    • 6.5.2. Baxter's Biosurgery
    • 6.5.3. Baxter's Clinical Nutrition Business
    • 6.5.4. Baxter's Hemophilia Therapies
    • 6.5.5. Baxter's Infusion Systems
    • 6.5.6. Baxter's Pharmaceuticals and IV Solutions
    • 6.5.7. Baxter's Renal Products
    • 6.5.8. Baxter's Business Performance
  • 6.6. Becton, Dickinson & Co.
    • 6.6.1. BD's International Operations
    • 6.6.2. BD Medical Business Segment
    • 6.6.3. BD Diagnostics
    • 6.6.4. BD Biosciences
    • 6.6.5. BD's Geographic Performance
    • 6.6.6. BD's Role in Designing Devices for Safe and Effective Injections and Infusions
      • 6.6.6.1. BD's Safety-Engineered Devices
      • 6.6.6.2. BD Auto-Disable Syringes
      • 6.6.6.3. BD's Insulin Syringes
      • 6.6.6.4. BD's Allergy Syringes
      • 6.6.6.5. BD's Tuberculin Syringes
      • 6.6.6.6. BD's Syringes and Needles
      • 6.6.6.7. BD's Safety-Lok Safety Syringes
      • 6.6.6.8. BD's Safety Glide Syringes
      • 6.6.6.9. BD's Eclipse Needles
      • 6.6.6.10. BD's Integra Syringes
      • 6.6.6.11. BD's PosiFlush Prefilled Syringes
  • 6.7. B. Braun
    • 6.7.1. B. Braun's Hospital Care Division
    • 6.7.2. B. Braun's Aesculap Division
    • 6.7.3. B. Braun's Out-Patient Market (OPM) Division
    • 6.7.4. B. Braun's Avitum Division
    • 6.7.5. B. Braun's Overall Business Performance
    • 6.7.6. Hospital Care Division's Business
    • 6.7.7. Aesculap Division's Business
    • 6.7.8. OPM Division's Business
    • 6.7.9. Avitum Division's Business
    • 6.7.10. B. Braun's Syringe Products
      • 6.7.10.1. Sterican® insulin needle
      • 6.7.10.2. Omnifix® 100 Duo
      • 6.7.10.3. Omnifix 100 Solo
      • 6.7.10.4. Injekt® 40 Duo
      • 6.7.10.5. Injekt 40 Solo
      • 6.7.10.6. Omnifix 40 Duo
      • 6.7.10.7. Omnifix 40 Solo
      • 6.7.10.8. Omnican® 100
      • 6.7.10.9. Omnican® 50
      • 6.7.10.10. Omnican® 20
      • 6.7.10.11. Omnican 40
      • 6.7.10.12. Omnican Pen
      • 6.7.10.13. Omnican® fine
  • 6.8. Bioject Medical Technologies, Inc.
    • 6.8.1. Bioject's Technology
    • 6.8.2. Bioject's Products
      • 6.8.2.1. Biojector 2000
      • 6.8.2.2. Bioject's Drug Reconstitution System
      • 6.8.2.3. Vitajet
      • 6.8.2.4. ZetaJet
  • 6.9. Catalent Pharma Solutions, Inc.
    • 6.9.1. Catalent's Development and Clinical Services Segment
    • 6.9.2. Catalent's Oral Technologies Segment
    • 6.9.3. Catalent's Sterile Technologies Segment
    • 6.9.4. Catalent's Packaging Services Segment
    • 6.9.5. Catalent's Syringe Solutions
  • 6.10. C.R. Bard, Inc.
    • 6.10.1. Bard's Vascular Business
    • 6.10.2. Bard's Urology Business
    • 6.10.3. Bard's Oncology Business
    • 6.10.4. Bard's Surgical Specialties Business
    • 6.10.5. Bard's Syringe Products
      • 6.10.5.1. Bard's Piston Syringes
      • 6.10.5.2. Bard's Bulb Syringes
  • 6.11. Coeur, Inc.
    • 6.11.1. Angiographic Syringes from Coeur
    • 6.11.2. CT Syringes from Coeur
  • 6.12. Covidien Ltd.
    • 6.12.1. Covidien's Medical Device Segment
    • 6.12.2. Covidien's Pharmaceutical Segment
    • 6.12.3. Covidien's Medical Supplies Segment
    • 6.12.4. Covidien's Syringes and Needles
      • 6.12.4.1. Magellan Safety Needles
      • 6.12.4.2. Magellan Safety Needle and Syringe Combination
      • 6.12.4.3. Magellan Insulin Safety Syringe
      • 6.12.4.4. Magellan Tuberculin Safety Syringe
      • 6.12.4.5. Magellan Safety Blood Collection Device
      • 6.12.4.6. Monoject Insulin Safety Syringe
      • 6.12.4.7. Monoject Tuberculin Safety Syringe
      • 6.12.4.8. Monoject 3 ml Safety Syringe
      • 6.12.4.9. Monoject 6 ml Safety Syringe
      • 6.12.4.10. Monoject 12 ml Safety Syringe
      • 6.12.4.11. SoftPack Hypodermic Needles
      • 6.12.4.12. Rigid Pack Hypodermic Needles
      • 6.12.4.13. Rigid Blunt Cannulas
      • 6.12.4.14. Soft Pack Tuberculin Syringes
      • 6.12.4.15. Rigid Pack Tuberculin Syringes
      • 6.12.4.16. SoftPack Insulin Syringes
      • 6.12.4.17. Rigid Pack Insulin Syringes
      • 6.12.4.18. Allergy Trays with Permanently Attached Needles
  • 6.13. Henke-Sass, Wolf GmbH
    • 6.13.1. Selected Products from Henke-Sass
      • 6.13.1.1. Two-Part Disposable Syringes 1-50 ml
      • 6.13.1.2. Three-Part Disposable Syringes 1-30 ml
      • 6.13.1.3. Disposable Needles HSW FINE-JECT
  • 6.14. Hindustan Syringes & Medical Devices, Ltd.
    • 6.14.1. Insulin Syringes from HMD
    • 6.14.2. HMD's Single-Use Needles
    • 6.14.3. HMD's Single Use Syringes
  • 6.15. Hi-Tech Medical Products Ltd.
  • 6.16. Hyaluron Contract Manufacturing (HCM)
    • 6.16.1. HCM's Major Markets
    • 6.16.2. HCM's Facility
      • 6.16.2.1. Inova SV-122 Syringe Filler
      • 6.16.2.2. Inova H3-5V Syringe Filler
      • 6.16.2.3. Inova VFVM-3031 Vial Filler
  • 6.17. International Medication System Ltd.
    • 6.17.1. Delivery Systems from IMS
    • 6.17.2. PCA Products from IMS
    • 6.17.3. Phytonadione Injection USP
    • 6.17.4. Lidocaine HCL Jelly, USP 2%
  • 6.18. Life-Shield Products, Inc.
  • 6.19. MedPro Safety Products, Inc.
    • 6.19.1. MedPro's Targeted Markets
    • 6.19.2. MedPro's Products
      • 6.19.2.1. Blood Collection Safety Needle
      • 6.19.2.2. Winged Safety Blood Collection Set
      • 6.19.2.3. Safety Syringe with Anti-Blunting Feature
      • 6.19.2.4. Prefilled Safety Syringes
      • 6.19.2.5. Key-Lok Needleless IV Systems
  • 6.20. Merit Medical Systems, Inc.
    • 6.20.1. Merit's Inflation Devices
    • 6.20.2. Merit's Hemostasis Valves
    • 6.20.3. Merit's Vascular Access Products
    • 6.20.4. Merit's Diagnostic Catheters, Guide Wires and Torque Devices
    • 6.20.5. Merit's Angiography and Accessories
    • 6.20.6. Merit's Safety and Waste Management Systems
    • 6.20.7. Merits Obesity Products
    • 6.20.8. Merit's Drainage Catheters and Accessories
    • 6.20.9. Merit's Parentesis and Pericardiocentesis Catheters
    • 6.20.10. Merit's Therapeutic Infusion Catheters
    • 6.20.11. Merit's Dialysis and Interventional Nephrology Products
    • 6.20.12. Coronary Control Syringes
    • 6.20.13. Medallion Syringes
    • 6.20.14. RXP Syringe
    • 6.20.15. VacLok Syringes
    • 6.20.16. Merit's Manufacturing Facilities
  • 6.21. Milestone Scientific
    • 6.21.1. Milestone Scientific's Product Platform
      • 6.21.1.1. STA Single Tooth Anesthesia System (STA System)
      • 6.21.1.2. CompuDent
      • 6.21.1.3. CompuMed
      • 6.21.1.4. The Wand
      • 6.21.1.5. The SafetyWand
  • 6.22. Novo Nordisk A/S
    • 6.22.1. Novo Nordisk's Global Diabetes Care Business
      • 6.21.1.1. Novo Nordisk's Diabetes Care Business in North America
      • 6.21.1.2. Novo Nordisk's Diabetes Care Business in Europe
      • 6.21.1.3. Novo Nordisk's International Business in Diabetes Care
      • 6.21.1.4. Novo Nordisk's Diabetes Care Business in Japan and Korea
      • 6.21.1.5. Insulin Pens and Needles from Novo Nordisk
    • 6.21.2. Pipeline Progress in Novo Nordisk
    • 6.21.3. Novo Nordisk's Modern Insulin Portfolio
  • 6.22. Owen Mumford Ltd.
    • 6.22.1. Autopen®
    • 6.22.2. Autoject 2
    • 6.22.3. Unifine Pentips
    • 6.22.4. UniGuard
  • 6.23. Plas-Pak Industries, Inc.
    • 6.23.1. Disposable Veterinary Syringes
    • 6.23.2. Dual Syringe and Dental Syringe from Plas-Pak
    • 6.23.3. Manual Dual Syringes
  • 6.24. Retractable Technologies, Inc.
    • 6.24.1. Retractable Technologies' VanishPoint Products
  • 6.25. Revolutions Medical Corporation
    • 6.25.1. RevVac Safety Syringe
  • 6.26. Safety Syringes, Inc.
    • 6.26.1. UltraSafe Needle Guards
    • 6.26.2. UltraSafe Passive Needle Guard
    • 6.26.3. UltraSafe Passive Needle Guards for Luer Lock and Luer Slip Syringe
    • 6.26.4. UltraSafe Automated Assembly
    • 6.26.5. UltraSafe Product Development
  • 6.27. Smiths Medical International/Medex, Inc.
    • 6.27.1. Smiths Medical's Markets
      • 6.27.1.1. Smiths' Medication Delivery Segment
      • 6.27.1.2. Smiths' Vital Care Segment
      • 6.27.1.3. Smiths' Safety Segment
    • 6.27.2. Syringes from Smiths
      • 6.27.2.1. Hypodermic Needle-Pro Fixed Needle TB Syringe
      • 6.27.2.2. Hypodermic Needle-Pro Device
      • 6.27.2.3. Hypodermic Needle-Pro Device & Syringe
      • 6.27.2.4. Hypodermic Needle-Pro Device for Insulin Injections
      • 6.27.2.5. Hypodermic Needle-Pro Fixed Needle Insulin Syringe
  • 6.28. Star Syringe Ltd.
    • 6.28.1. Star Syringe's Alliances
    • 6.28.2. Star Syringe Products
      • 6.28.2.1. K Safety Technology: K1 Auto-disable Syringe Mechanism
      • 6.28.2.2. K3 Safety Cap
      • 6.28.2.3. K5 Aspiration
  • 6.29. Terumo Medical Corporation
    • 6.29.1. Terumo's Syringe Products
      • 6.29.1.1. SurGuard2 Syringes with Safety Needle
      • 6.29.1.2. SurGuard2 Safety Needles
      • 6.29.1.3. Terumo Hypodermic Needles
      • 6.29.1.4. Terumo Hypodermic Syringes without Needle
      • 6.29.1.5. Terumo Tuberculin Syringes
      • 6.29.1.6. Terumo Hypodermic Syringes with Needle
      • 6.29.1.7. SurSaver 1CC syringes with Low Dead Space
      • 6.29.1.8. Terumo Dental Needles
      • 6.29.1.9. Terumo Spinal Needles
      • 6.29.1.10. SurGuard Safety Insulin Syringes
      • 6.29.1.11. Terumo Insulin Syringes
      • 6.29.1.12. Thinpro Insulin Syringes for Retail Customers
  • 6.30. UltiMed, Inc.
    • 6.30.1. UltiCare Insulin Syringes
    • 6.30.2. UltiCare Pen Needles
  • 6.31. Unilife Medical Solutions, Ltd.
    • 6.31.1. Unilife's Solutions
    • 6.31.2. Prefilled Syringes from Unilife
    • 6.31.3. Clinical (Hypodermic) Syringes from Unilife
    • 6.31.4. Unilife's Self Injection Systems
      • 6.31.4.1. Auto-Injectors
      • 6.31.4.2. Unilife's Auto-Infusers
    • 6.31.5. Unilife's Syringe Products
      • 6.31.5.1. Unifill Syringe
      • 6.31.5.2. Unitract 1 ml Syringes
      • 6.31.5.3. Unifill Select
      • 6.31.5.4. Unifill Rita
      • 6.31.5.5. Unifill EZMix syringes
      • 6.31.5.6. Unilife Autoinfuser
  • 6.32. Vetter Pharma-Fertigung GmbH & Co.
    • 6.32.1. Vetter Services and Solutions
    • 6.32.2. Vetter's Dual-Chamber Technology
  • 6.33. Vita Needle Company, Inc.
    • 6.33.1. Disposable Stainless Steel Needle Blunts from Vita Needle
    • 6.33.2. Teflon Dispensing Needles
    • 6.33.3. Vita Needle's Polypropylene Needles
    • 6.33.4. Vita Needle's Taper Tip Needles
  • 6.34. West Pharmaceutical Services, Inc.
    • 6.34.1. West's Business Segments
      • 6.34.1.1. Packaging Systems Segment
      • 6.34.1.2. Delivery Systems Segment
    • 6.34.2. West's Syringe Products
      • 6.34.2.1. The West ConfiDose Autoinjector System
      • 6.34.2.2. West's Prefillable Syringes
      • 6.34.2.3. Plungers
      • 6.34.2.4. Needle Shields
      • 6.34.2.5. Tip Caps
  • 6.35. Wuxi Yushou Medical Appliances Co., Ltd.
  • 6.36. Ypsomed Holding AG
    • 6.36.1. Future Trends in Self Medication: Ypsomed Holding's Perceptions
    • 6.36.2. ServoPen
    • 6.36.3. YpsoPen Twist
    • 6.36.4. UnoPen
    • 6.36.5. LyoTwist
    • 6.36.6. YpsoMate
    • 6.36.7. Mylife OmniPod insulin patch pump

APPENDIX

  • Appendix 1: Global Market for Conventional Injectables
  • Appendix 1.1: Global Market for Drug Delivery Devices
  • Appendix 1.2: Evolving Trends in Insulin Delivery
  • Appendix 1.2.1: Alternative Modes of Insulin Delivery
  • Appendix 1.2.2: Insulin Injection Ports
  • Appendix 1.2.3: Continuous Subcutaneous Insulin Infusion Pumps
  • Appendix 1.2.4: Transdermal Patches
  • Appendix 1.2.5: Inhalable Insulin Devices
  • Appendix 1.3: Global Burden of Diabetes
  • Appendix 1.3.1: Market for Insulin Delivery Devices
  • Appendix 1.3.2: Leaders in Insulin Delivery Devices
  • Appendix 1.3.3: Global Insulin Consumption
  • Appendix 1.3.4: Global Market for Insulin
  • Appendix 1.4: Global Diabetes Care Market Share by Company
  • Appendix 1.4.1: Global Insulin Market by Molecule Type
  • Appendix 1.4.2: Global Insulin Market by Geography
  • Appendix 1.4.3: Global Diabetes Care Market by Treatment Class
  • Appendix 1.5: Growth of Modern Insulin
  • Appendix 1.5.1: Global Modern Insulin Market Shares
  • Appendix 1.6: U.S. Insulin Market by Segment
  • Appendix 1.6.1: U.S. Modern Insulin Volume Market Shares
  • Appendix 1.7: E.U. Insulin Market by Segment
  • Appendix 1.7.1: E.U. Modern Insulin Volume Market Share by Company
  • Appendix 1.8: Chinese Insulin Market by Segment
  • Appendix 1.8.1: China Insulin Volume Market Shares
  • Appendix 1.9: Japan Insulin Market by Segment
  • Appendix 1.9.1: Japan Modern Insulin Market Share by Company
  • Appendix 2: Sharps Safety Products
  • Appendix 3: Syringe Needle Terminology
  • Appendix 4: Medication Errors and Syringe Safety
  • Appendix 4.1: Injectable Medication Errors
  • Appendix 4.2: Frequency of Syringe Usage
  • Appendix 4.3: Labeling Injectable Medications
  • Appendix 4.4: Challenges of Labeling
  • Appendix 4.5: Benefits of a Write-On Stripe
  • Appendix 4.6: Nurses Influence on Selection of Sharp Devices
  • Appendix 4.7: Needlestick Injuries
  • Appendix 4.8: Prevention of Needlestick Injuries
  • Appendix 4.9: Protection from Needlestick Injuries

INDEX OF FIGURES

  • Figure 2.1: Filling and Packaging of Prefilled Syringes
  • Figure 4.1: Most Common Instances When Needlesticks Occur
  • Figure 4.2: Needlestick Injuries in Massachusetts at Healthcare Facilities with Safety vs. Standard Syringes
  • Figure 4.3: Indicative Pricing Chart for Safety Features
  • Figure 5.1: Syringe Sizes Required for Injectable Drugs
  • Figure 5.2: Global Market for Disposable Syringes, 2012-2019
  • Figure 5.3: Global Market for Disposable Syringes by Segmentation, 2012
  • Figure 5.4: Global Market for Safety Syringes by Segmentation (Total $1.96 Billion), 2011
  • Figure 5.5: Combined Market for Drug Delivery Syringe Devices, 2010-2015
  • Figure 5.6: Breakdown of U.S. Syringe Market
  • Figure 5.7: Types of Safety Syringes used in the U.S. Healthcare Facilities
  • Figure 5.8: Percentage of U.S. Adoption of Safety Syringes, 2012-2019
  • Figure 5.9: The Total Disposable Syringe Market in the U.S., 2012-2019
  • Figure 5.10: The U.S. Market for Hypodermic Safety Syringes, 2012-2019
  • Figure 5.11: European Overall Market for Disposable Syringes, 2011-2019
  • Figure 5.12: European Adoption of Safety Syringes, 2012-2019
  • Figure 5.13: Market Share of Prefilled Syringes by Geography
  • Figure 5.14: Number of Drugs in the Core Therapeutic Areas for Prefilled Syringes
  • Figure 5.15: Global Market for Prefilled Syringes, 2012-2019
  • Figure 5.16: Steady Growth of Global Prefilled Syringe Unit Consumption, 2012-2019
  • Figure 5.17: World vs. U.S. Market for Prefilled Syringes, 2012-2019
  • Figure 5.18: Consumption of Prefilled Syringes by Pharmaceutical Company
  • Figure 5.19: Pharmaceutical Consumption of Prefilled Syringes by Therapeutic Drug Class
  • Figure 5.20: Global Market for Prefilled Pain Management Drugs, 2012-2019
  • Figure 5.21: Global Sales of Enbrel in Prefilled Syringes
  • Figure 5.22: Global Market for Prefilled Psoriasis Drugs, 2012-2019
  • Figure 5.23: Global Market for Prefilled Anemia Drugs, 2012-2019
  • Figure 5.24: Global Market for Prefilled Insulin, 2012-2019
  • Figure 5.25: Growth of Prefilled Insulin Devices and Decline of Vials and Syringes
  • Figure 5.26: Global Market for Oncology Drugs in Prefilled Syringes, 2012-2019
  • Figure 5.27: Global Market for Multiple Sclerosis Drugs in Prefilled Syringes, 2012-2019
  • Figure 5.28: Market Share for Multiple Sclerosis Drugs in Prefilled Syringes by Company
  • Figure 5.29: Global Market for Arthritis Drugs in Prefilled Syringes, 2012-2019
  • Figure 5.30: Percent Growth of Vaccines in Prefilled Syringes, 2012-2019
  • Figure 5.31: Market Share for Vaccines in Prefilled Syringes by Company
  • Figure 5.32: Market Share for Anti-Coagulants in Prefilled Syringes by Company
  • Figure 5.33: Market Share for Anti-Inflammatory Drugs in Prefilled Syringes
  • Figure 5.34: Market Share for Hematology Drugs in Prefilled Syringes by Company
  • Figure 5.35: Market Share for Obstetrics Drugs in Prefilled Syringes by Company
  • Figure 5.36: Global Market for Insulin Pen, 2012-2019
  • Figure 5.37: Global Market for Auto-Injectors/Auto-Infusers, 2012-2019
  • Figure 5.38: U.S. Leaders in Insulin Pumps
  • Figure 5.39: Market for Self-Injection Syringes, 2012-2019
  • Figure 6.1: BD Business Performance by Segment, 2012
  • Figure 6.2: Performance of BD Medical Segment, 2012
  • Figure 6.3: Performance of BD Diagnostics Segment, 2012
  • Figure 6.4: BD's Geographic Performance, 2012
  • Figure 6.5: Share of Bioject's Business by Customer
  • Figure 6.6: Bioject's Business by Product Line
  • Figure 6.7: Bioject's Business by Geography
  • Figure 6.8: Catalent's Revenue by Segment
  • Figure 6.9: Retractable Technologies' Business by Geography
  • Figure 6.10: Smiths' Market by Segment
  • Figure 6.11: Insulin Market by Geography, 2009-2015
  • Figure 6.12: Global Insulin Market by Manufacturers, 2009-2015
  • Figure A.1.1: Global Market for Conventional Injectables, 2012-2019
  • Figure A.1.2: Global Market for Injection, Infusion and Vascular Access Devices, 2012-2019
  • Figure A.1.3: Global Burden of Diabetes, 2010-2030
  • Figure A.1.4: Global Market for Insulin Delivery Devices, 2009-2016
  • Figure A.1.5: Insulin Delivery Devices Worldwide Market Shares by Company
  • Figure A.1.6: Insulin Consumption in Selected Countries
  • Figure A.1.7: Global Market for Insulin, 2012-2019
  • Figure A.1.8: Global Diabetes Care Market Share by Company, 2012
  • Figure A.1.9: Global Insulin Market Breakup by Molecule (~ $19 Billion), 2012
  • Figure A.1.10: Global Insulin Market by Geography, 2012
  • Figure A.1.11: Global Diabetes Care Market by Treatment Class, 2002-2012
  • Figure A.1.12: Shares of Human Insulin and Modern Insulin in Global Insulin Market, 2007-2012
  • Figure A.1.13: Global Insulin Volume Market Shares by Company, 2007-2012
  • Figure A.1.14: U.S. Insulin Market by Segment, 2007-2012
  • Figure A.1.15: U.S. Modern Insulin Volume Market Share by Company, 2007-2012
  • Figure A.1.16: E.U. Insulin Market by Segment, 2007-2012
  • Figure A.1.17: E.U. Modern Insulin Volume Market Share by Company, 2007-2012
  • Figure A.1.18: Chinese Insulin Market by Segment, 2007-2012
  • Figure A.1.19: China Insulin Volume Market Share by Company, 2012
  • Figure A.1.20: Japan Insulin Market by Segment, 2007-2012
  • Figure A.1.21: Japan Modern Insulin Market Share by Company, 2007-2012
  • Figure A.4.1: Timing of Needlestick Injuries

INDEX OF TABLES

  • Table 2.1: Components of a Prefilled Syringe
  • Table 2.2: Key Advantages of Prefilled Syringes
  • Table 2.3: Insulin Pens Available in the U.S.
  • Table 2.4: Types of Insulins Used in Cartridges
  • Table 2.5: Aspects of Insulin Pens to be considered
  • Table 2.6: User Characteristics of Insulin Pens
  • Table 5.1: Selected Injectable Therapeutics and Vaccines Available in the U.S. Market
  • Table 5.2: Key Advantages of Prefilled Syringes
  • Table 5.3: Pharmaceutical Share of Key Prefilled Therapeutic Market
  • Table 5.4: Key Prefilled Products
  • Table 5.5: Biotech Blockbusters Available in Vials and Prefilled Syringes
  • Table 6.1: Albert David's Syringes with Needles
  • Table 6.2: Albert David's Needles
  • Table 6.3: Syringes from Alshifa
  • Table 6.4: BD's Auto-Disable Syringes
  • Table 6.5: Insulin Syringes from BD
  • Table 6.6: BD's Allergy Syringes
  • Table 6.7: BD's Tuberculin Syringes
  • Table 6.8: BD's Sterile, Single-Use Syringes and Needles
  • Table 6.9: BD's Safety-Lok Safety Syringes
  • Table 6.10: BD's Safety Glide Syringes
  • Table 6.11: BD's Eclipse Syringes
  • Table 6.12: BD's Integra Syringe
  • Table 6.13: BD's PosiFlush Prefilled Syringes
  • Table 6.14: Bard's Piston Syringes
  • Table 6.15: Bard's Bulb Syringes and Trays, 2009
  • Table 6.16: Angiographic Syringes from Coeur
  • Table 6.17: CT Syringes from Coeur
  • Table 6.18: HMD's Dispovan Insulin Syringes
  • Table 6.19: HMD's Single-Use Needles
  • Table 6.20: HMD's Single Use Syringes
  • Table 6.21: Hi-Tech Single-Use Syringes
  • Table 6.22: Hi-Tech's Single-Use Insulin Syringes
  • Table 6.23: HCM's Contract Manufacturing Categories
  • Table 6.24: Syringes from IMS
  • Table 6.25: PCA Syringes from IMS
  • Table 6.26: Phytonadione Injection USP from IMS
  • Table 6.27: Lidocaine Prefilled Syringes from IMS
  • Table 6.28: Life-Shield's Syringe Products
  • Table 6.29: Estimated Market for MedPro's Targeted Product Sectors
  • Table 6.30: Autopen Products from Owen Mumford
  • Table 6.31: Autoject Products from Owen Mumford
  • Table 6.32: Unifine Products from Owen Mumford
  • Table 6.33: Retractable Technologies' VanishPoint Syringes
  • Table 6.34: Smiths' Pro Fixed Needle TB Syringes
  • Table 6.35: Smiths' Needle-Pro with Needle Protection Devices
  • Table 6.36: Smiths' Needle-Pro Syringe and Needle with Needle Protection Device
  • Table 6.37: Smiths' Needle-Pro Needle Protection Device for Insulin Injections
  • Table 6.38: Smiths' Needle-Pro Fixed Needle Insulin Syringe
  • Table 6.39: SurGard2 Syringes with Safety Needle
  • Table 6.40: Terumo's SurGard2 Safety Needles
  • Table 6.41: Terumo's Hypodermic Needles
  • Table 6.42: Terumo's Hypodermic Syringes without Needle
  • Table 6.43: Terumo's Tuberculin Syringes
  • Table 6.44: Terumo's Hypodermic Syringes with Needle
  • Table 6.45 Terumo's SurSaver 1 cc Syringes with Low Dead Space
  • Table 6.46: Terumo's Dental Needles
  • Table 6.47: Terumo's Spinal Needles
  • Table 6.48: Terumo's SurGard Safety Insulin Syringes
  • Table 6.49: Terumo's Insulin Syringes
  • Table 6.50: Thinpro Insulin Syringes
  • Table 6.51: UltiMed's UltiCare Insulin Syringes
  • Table 6.52: UltiCare Pen Needles
  • Table 6.53: Vita Needle's Stainless Steel Needle Blunts
  • Table 6.54: Vita Needle's Teflon Dispensing Needles
  • Table 6.55: Vita Needles Polypropylene Needles
  • Table 6.56 Vita Needle's Taper Tip Needles
  • Table A. 1.1: Alternative Modes of Insulin Delivery
  • Table A. 1.2: Types of Insulin Used in Pump Therapy
  • Table A. 1.3: Insulin Pumps Assessed by AFB TECH Company in 2004 and 2008 240
Back to Top